Evidence map›Paper›PMID 36771026›Full record

ArticleMolecules (Basel, Switzerland)2023

Evaluation of Ruthenium(II)

Ibrahim S Al Nasr, Waleed S Koko, Tariq A Khan, Nevin Gürbüz, Ismail Özdemir, Naceur Hamdi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Cu(I)-N-Heterocyclic carbenes as potent inhibitors of SARS-CoV-2 replication.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  3. Review
  4. Platinum Group Metals against Parasites: State of the Art and Future Perspectives.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2025
    Review
  5. Article
  6. Synthesis of NovelAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ibrahim S Al NasrDepartment of Biology, College of Science and Arts, Qassim University, Unaizah 51911, Saudi Arabia.ORCID 0000-0003-4690-1050
Waleed S KokoDepartment of Science Laboratories, College of Science and Arts, Qassim University, Ar Rass 51921, Saudi Arabia.
Tariq A KhanDepartment of Clinical Nutrition, College of Applied Health Sciences, Qassim University, Ar Rass 51921, Saudi Arabia.
Nevin GürbüzDepartment of Chemistry, Faculty of Science and Art, İnönü University, Malatya 44280, Turkey.
Ismail ÖzdemirDepartment of Chemistry, Faculty of Science and Art, İnönü University, Malatya 44280, Turkey.ORCID 0000-0001-6325-0216
Naceur HamdiDepartment of Chemistry, College of Science and Arts at ArRass, Qassim University, Ar Rass 51921, Saudi Arabia.
Qassim University · SAInonu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of [RuCl

Indexed as

Anti-Infective AgentsAntineoplastic AgentsCoordination ComplexesRutheniumAntioxidantsCymenesLigandsMethane4-cymeneAnti-Infective AgentsAntineoplastic AgentsAntioxidantscarbeneCoordination ComplexesCymenesLigandsMethaneRuthenium5,6-dimethylbenzimidazolium saltsantimicrobialantioxidantenzyme inhibitionHCT-116HepG-2LeishmaniaN-Heterocyclic carbenerutheniumToxoplasma

Identifiers

PMID36771026
PMCPMC9921063
OpenAlexW4318817837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.